AAAAAA
Results:
1-14
|
Results: 14
Authors:
Lasker, BA
Elie, CM
Lott, TJ
Espinel-Ingroff, A
Gallagher, L
Kuykendall, RJ
Kellum, ME
Pruitt, WR
Warnock, DW
Rimland, D
Mcneil, MM
Reiss, E
Citation: Ba. Lasker et al., Molecular epidemiology of Candida albicans strains isolated from the oropharynx of HIV-positive patients at successive clinic visits, MED MYCOL, 39(4), 2001, pp. 341-352
Authors:
Carrillo-Munoz, AJ
Brio, S
Quindos, G
Palacin, C
Guglietta, A
Espinel-Ingroff, A
Citation: Aj. Carrillo-munoz et al., Sertaconazole: In-vitro antifungal activity against vaginal and other superficial yeast isolates, J CHEMOTHER, 13(5), 2001, pp. 555-562
Authors:
Rex, JH
Pfaller, MA
Walsh, TJ
Chaturvedi, V
Espinel-Ingroff, A
Ghannoum, MA
Gosey, LL
Odds, FC
Rinaldi, MG
Sheehan, DJ
Warnock, DW
Citation: Jh. Rex et al., Antifungal susceptibility testing: Practical aspects and current challenges, CLIN MICROB, 14(4), 2001, pp. 643-658
Authors:
Espinel-Ingroff, A
Boyle, K
Sheehan, DJ
Citation: A. Espinel-ingroff et al., In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature, MYCOPATHOLO, 150(3), 2001, pp. 101-115
Authors:
Espinel-Ingroff, A
Citation: A. Espinel-ingroff, Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi, J CLIN MICR, 39(4), 2001, pp. 1360-1367
Authors:
Espinel-Ingroff, A
Citation: A. Espinel-ingroff, In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi, J CLIN MICR, 39(3), 2001, pp. 954-958
Authors:
Espinel-Ingroff, A
Bartlett, M
Chaturvedi, V
Ghannoum, M
Hazen, KC
Pfaller, MA
Rinaldi, M
Walsh, TJ
Citation: A. Espinel-ingroff et al., Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation, ANTIM AG CH, 45(6), 2001, pp. 1828-1835
Authors:
Espinel-Ingroff, A
Citation: A. Espinel-ingroff, Germinated and nongerminated conidial suspensions for testing of susceptibilities of Aspergillus spp. to amphotericin B, itraconazole, posaconazole, ravuconazole, and voriconazole, ANTIM AG CH, 45(2), 2001, pp. 605-607
Authors:
Espinel-Ingroff, A
Warnock, DW
Vazquez, JA
Arthington-Skaggs, BA
Citation: A. Espinel-ingroff et al., In vitro antifungal susceptibility methods and clinical implications of antifungal resistance, MED MYCOL, 38, 2000, pp. 293-304
Authors:
Barry, AL
Pfaller, MA
Brown, SD
Espinel-Ingroff, A
Ghannoum, MA
Knapp, C
Rennie, RP
Rex, JH
Rinaldi, MG
Citation: Al. Barry et al., Quality control limits for broth microdilution susceptibility tests of tenantifungal agents, J CLIN MICR, 38(9), 2000, pp. 3457-3459
Authors:
Aller, AI
Martin-Mazuelos, E
Lozano, F
Gomez-Mateos, J
Steele-Moore, L
Holloway, WJ
Gutierrez, MJ
Recio, FJ
Espinel-Ingroff, A
Citation: Ai. Aller et al., Correlation of fluconazole MICs with clinical outcome in Cryptococcal infection, ANTIM AG CH, 44(6), 2000, pp. 1544-1548
Authors:
Espinel-Ingroff, A
Barchiesi, F
Hazen, KC
Martinez-Suarez, JV
Scalise, G
Citation: A. Espinel-ingroff et al., Standardization of antifungal susceptibility testing and clinical relevance (vol 36, pg 68, 1998), MED MYCOL, 37(2), 1999, pp. 147-147
Authors:
Espinel-Ingroff, A
Vazquez, JA
Boikov, D
Pfaller, MA
Citation: A. Espinel-ingroff et al., Evaluation of DNA-based typing procedures for strain categorization of Candida spp., DIAG MICR I, 33(4), 1999, pp. 231-239
Authors:
Espinel-Ingroff, A
Pfaller, M
Messer, SA
Knapp, CC
Killian, S
Norris, HA
Ghannoum, MA
Citation: A. Espinel-ingroff et al., Multicenter comparison of the Sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory Standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms, J CLIN MICR, 37(3), 1999, pp. 591-595
Risultati:
1-14
|